When should epidemiological evidence alone - without laboratory confirmation of product contamination - be sufficient to trigger a voluntary food recall?

Answer Explanations

• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-3716
  A case-by-case risk-based approach is most appropriate, as strong epidemiological evidence may justify action when the potential harm is significant and timely intervention is critical, even in the absence of laboratory 
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-957551
  Given risk assessment is really about probability statistics mixed with the socio-political-economic responsibilities to manage that probability as low as possible, each situation is unique and context should always be considered.  Thus, it is better to make decisions on a case-by-case decision and not mandate a one-size fits all decision matrix.  
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-37602
  Strong epidemiological evidence, say clear, consistent association across cases, dose-response patterns, or high relative risk, do provide sufficient confidence to act when laboratory confirmation is delayed or inconclusive. However, when the potential health impact is severe or widespread, precautionary principle comes handy to supports initiating a recall to protect public health even in the absence of direct product testing evidence.
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-210880
  Decisions under incomplete evidence should not rely on a single criterion. Epidemiological signals can be strong indicators of risk, but their interpretation must be integrated with the severity of potential harm, population vulnerability, and exposure scale.
  In practice, decision-making in high-risk settings often requires acting before full confirmation, while also avoiding unnecessary overreaction. Therefore, a case-by-case risk assessment framework is essential, balancing the strength of epidemiological evidence with the potential consequences of both action and inaction.
  This approach is consistent with operational decision-making in other fields, where safety, uncertainty, and real-world constraints must be integrated rather than treated independently.
  This challenge parallels decision-making in clinical radiopharmaceutical production, where actions must often be taken under uncertainty before complete analytical confirmation.
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-69551
  For recall decisions to have merit, they should not be based on a particular kind of data, but on the weight of the overall evidence. Not all epidemiological evidence is equally strong – a well-designed case‐control study with a high odds ratio is stronger than just a simple time cluster. And the severity of an illness matters, too: for life‐threatening conditions such as infant botulism or HUS from E. coli O157:H7, a lower threshold would be more appropriate. In addition, the cost of waiting for lab confirmation is high especially when the exposures are to a population at risk with infants or young children. Meanwhile a recall based only on weak epidemiological results could harm manufacturers and damage the public’s confidence in the recall system. A risk assessment designed to assess specific risks on a case-by-case basis permits the regulator to consider a range of considerations epi strength, harm severity, population vulnerability, product distribution in determining what constitutes a proportionate risk. This approach fits the way in practice now that outbreak investigations are carried out both with the FDA and CDC.
  
  
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-414344
  An assessment should use all available evidence and the weight of that evidence. This should be a consensus judgement of a diversified expert group.
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-890708
  It is still necessary to make a comprehensive evaluation based on time, environment, and the actual situation at that time, as well as the experimental results of the laboratory under the same conditions.
• Only when vulnerable populations (infants, elderly, immunocompromised) are at risk

  user-433580
  Needed as and when necessary 
• Always - strong epidemiological evidence is sufficient on its own

  user-15416
  we cannot have doubt about products contamination in particolary for voulnerable people
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-157767
  The recall of food products suspected to be contaminated should be managed on a case-by-case basis, as the severity and nature of harm associated with different contaminants vary widely depending on their biological, chemical, or physical properties. 

   -For example, contamination with pathogenic microorganisms such as Salmonella enterica may pose an acute public health risk requiring immediate and widespread recall, whereas low-level exposure to certain chemical residues may necessitate a more measured risk assessment approach. 

  - The decision-making process should incorporate scientific risk assessment principles, including hazard identification, dose–response evaluation, exposure assessment, and risk characterization, to ensure that the response is proportionate to the actual threat posed. 

   -Therefore, an evidence-based, context-specific recall strategy is essential to effectively protect public health while minimizing unnecessary economic losses and food waste within the supply chain.
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-683654
  There are very many people in need of food and food should not be treated like drugs.
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-789652
  In public health practice, strong epidemiological evidence (e.g., consistent exposure and outcome association, high relative risk, clear temporal relationship) can sometimes justify a recall even without laboratory confirmation especially when the potential harm is severe or widespread. However, decisions must balance uncertainty, economic impact, and urgency, making a risk-based, context-specific approach the standard.
  
  
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-353654
  Every decision should consider possible costs and assessed probabilities. A moderately suspected problem with enormous consequences should lead to immediate action (there is a 5% chance of a bomb in the building? evacuate!). A risk that is relatively mild in magnitude allows for seeking more certainty  What methods created the evidence that produces the belief is not in itself important.
• It depends on a case-by-case risk assessment weighing epi strength, harm severity, and population exposure

  user-162882
  Context specific risk assment enables to propose early measurs.
• Always - strong epidemiological evidence is sufficient on its own

  user-958242
  For voluntary food  Recall without labarotory confirmation, strong epidemiological evidence is sufficient alongwith esimtaing population exposure.
  A single case or few  cases of food contamination could not be assigned as a causative and being for food recall.These are to weighed with little more case load study with same food being used  and matching epidemiological features as well as studying clinical and toxicological patterns .In this uncertainity , it is not asked whether it is  acute or chronic contamination evaluation.
  
  A same food contamination with clinical manifestations  occuring  at different locations is strong epidemiological evidence of food recall.
  
  Age is important factor in assesing effects of food contamination.
  The same contaminated foodmay manifest in chilrdren or elderly but not in adult but being toxic in particular age and  with being in strength of particular age group  needs food recall without lab confirmation